NGFR-AS1: A Potential Drug Target and Biomarker (G100288866)

Target Name: NGFR-AS1

NCBI ID: G100288866

NGFR-AS1

Other Name(s): NGFR antisense RNA 1

NGFR-AS1: A Potential Drug Target and Biomarker

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has identified NGFR-AS1 as a potential drug target for the treatment of various diseases, including diabetes, heart disease, and neurodegenerative disorders. NGFR-AS1 is a non-coding RNA molecule that has been shown to play a role in the regulation of gene expression and has been linked to the development and progression of various diseases.

One of the key functions of NGFR-AS1 is its role in the regulation of stem cell proliferation and differentiation. NGFR-AS1 has been shown to promote the self-renewal and survival of stem cells, which are important for the development and maintenance of tissues and organs. This function of NGFR-AS1 has important implications for the treatment of diseases that are characterized by the destruction of tissues and organs, such as cancer and neurodegenerative disorders.

NGFR-AS1 has also been shown to play a role in the regulation of angiogenesis, the process by which new blood vessels are formed. This function of NGFR-AS1 has important implications for the treatment of diseases that are characterized by the formation of excess blood vessels, such as cancer and cardiovascular disease.

In addition to its role in stem cell proliferation and angiogenesis, NGFR-AS1 has also been shown to play a role in the regulation of inflammation. This function of NGFR-AS1 has important implications for the treatment of diseases that are characterized by inflammation, such as autoimmune disorders and inflammatory bowel disease.

NGFR-AS1 has also been shown to play a role in the regulation of cellular signaling pathways that are involved in the development and progression of diseases. This function of NGFR-AS1 has important implications for the treatment of diseases that are characterized by the disruption of normal cellular signaling pathways, such as those that are associated with cancer and neurodegenerative disorders.

NGFR-AS1 has been shown to play a role in the regulation of gene expression in a wide range of organisms, including humans. This suggests that NGFR-AS1 may be a useful drug target for the treatment of a wide range of diseases. However, further research is needed to fully understand the role of NGFR-AS1 in disease and to develop effective treatments based on its properties.

In conclusion, NGFR-AS1 is a promising drug target and biomarker for the treatment of a wide range of diseases. Further research is needed to fully understand its role in disease and to develop effective treatments based on its properties.

Protein Name: NGFR Antisense RNA 1

The "NGFR-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NGFR-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets